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The important role of human microbiota in both health and disease has become increasingly recognised. 126 Microbial communities encode millions of genes and associated functions which act in concert with those 127 of human cells to maintain homeostasis. 1 Numerous studies have now established the microbiota as an 128 important contributor to essential mammalian functions such as metabolism 2 , biosynthesis 3 , 129 neurotransmission 4,5 and immunomodulation 6, 7 . Characterizing the composition and diversity of normal, 130 healthy microbial communities is a cornerstone to developing our understanding of dysbiosis, 131 pathophysiology and, ultimately, directing therapy. To this end, advent of next-generation sequencing 132 (NGS) has revolutionised our appreciation of the host microbiota and its polymicrobial nature. 8,9 133 In many cases the entire microbial community -commensal, symbiotic, pathogenic bacteria, fungi, 134 archaea, and viruses -play critical roles in both health and disease pathogenesis. The host-microbiota 135 interface is particularly important in chronic mucosal inflammatory conditions where the microbiota 136 interact directly with the host. These conditions are often poorly understood, multifactorial in nature, have 137 heterogeneous clinical presentations and vary in treatment response. 10,11 Furthermore, single causative 138 pathogens are rarely identified, and culture directed-antibiotics often fail to demonstrate efficacy. 12 It is 139 plausible that a better understanding of the microbiome of such conditions may be key to unraveling their 140 underlying pathogenesis. 141
The sinonasal mucosa is continuously exposed to external particulate matter and microbes, but it is 142 relatively immunodeplete with no native secondary lymphoid organ systems. 13 The sinus microbiota is 143 thought to play key roles in multiple extra-nasal conditions, such as providing a nidus of recurrent 144 infection in cystic fibrosis patients 14 , and otitis media. 15 In addition, there is evidence of microbial 145 influences in the development, progression and severity of chronic rhinosinusitis (CRS). 16 This 146 multifactorial condition, with an estimated world-wide prevalence of approximately 10%, 11 represents one 147 of the most common diagnoses for inappropriate antibiotic prescription and is a source of significant 148 morbidity and healthcare costs. 11, [17] [18] [19] To date, despite a number of well-designed research efforts to 149 define the nature of the sinonasal microbiome and its role in CRS pathogenesis, many uncertainties 150 persist. This is in part due to the difficulty in bacterial collection from the nose itself. Unlike the gut and 151 oral cavity where the bacterial burden is high and access to microbiota relatively easy (either via faecal 152 samples or oral wash), 20,21 the sinonasal tract has a low microbial burden and access is difficult due to 153 both the narrow nasal orifice and discomfort for the awake patient. Therefore, a replicable sample with 154 appropriate bacterial abundance for 16S rRNA gene sequencing is currently attainable only during nasal 155 surgery. To date, the majority of published studies have been small in size, with heterogeneous patient 156 populations and inconsistency in collection methods, sample site, processing techniques and 157 bioinformatics pipelines. 22 Ultimately, the consequence has been non-comparable results with no 158 universal consensus on the constituents of the healthy sinonasal microbiota or the dysbiosis that occurs in 159 disease. 23-29 160 To address these limitations, we investigate the sinonasal microbiome using 16S rRNA gene-sequencing 161 on a large, multi-centre, international cohort implementing consistent sampling, processing and 162 bioinformatics methods. We aim to (1) Pseudomonas made up the remainder of the ten most abundant genera. The lower prevalence of these 187 remaining organisms could suggest that aside from Corynebacterium and Staphylococcus, there is a high 188 degree of variability in the constituents of a healthy upper airway microbiome. 189
Microbiome composition is altered in CRSwNP and by geographical location 190
To explore influences of microbial composition, we examined the taxonomic profiles of our patient 191 cohort once grouped by (1) disease cluster and (2) centre of origin ( Figure 1 organisms also remained stable between controls and CRSwNP but for two genera ( Figure 1A) : 196
Corynebacterium was found to be significantly reduced in CRSwNP when compared to controls (40.29% 197 vs 50.43%; mixed model analysis; p = 0.02) whilst Streptococcus was increased (7.21% vs 2.73%; mixed 198 model analysis; p = 0.032). Interestingly, the most commonly cultured pathogens in CRS, Staphylococcus 199 and Pseudomonas were similar between all cohorts. 200 By contrast, comparisons between centres revealed a higher degree of variability in the microbiome 211 composition ( Figure 1B ). Samples from Amsterdam were significantly different from the remainder of the 212 cohort, with increased Staphylococcus (51.94%) and marked depletion of Corynebacterium (15.51%). 213
Amongst the remaining centres, each appeared to have some variability, with individual regions 214 displaying increased or decreased relative abundance in specific taxa. Streptococcus, for example, made 215 up 13.48% of the Sydney microbiome, but was almost absent amongst the Adelaide (0.65%), Auckland 216 (0.45%), Massachusetts (0.32%) and Thailand (0.72%) cohorts. Similar variability can be seen for almost 217 all bacterial taxa examined ( Figure 1B ). While centres' samples were appeared fairly similar in microbial 218 composition, these results would suggest that centre-specific microbiome profiles can be found. This 219 variability may account for some of the inconsistencies observed in the literature, particularly between 220 findings from different institutes. 221
Microbial diversity is influenced by geographical location 222
Alpha diversity amongst cohorts was performed utilising Faith's Phylogenetic Diversity (PD) index. 31 223
Comparison between disease states demonstrated no significant differences between controls, CRSsNP 224 and CRSwNP (Figure 2A ). Overall, alpha diversity was significantly different between centres (Kruskall-225 Wallis; p < 0.001; Figure 2B ). Of particular interest was the finding of a significantly lower alpha 226 diversity for samples from Amsterdam compared to the other centres (mean PD = 1.27, p < 0.01). This 227 may be related to the compositional findings of high staphylococcal abundance in Amsterdam. 228 Multivariate analysis on the beta diversity distance matrix was done using PERMANOVA (with 999 241 permutations) to explore the significance of the diagnosis versus the centre variables in a single model. 242
This showed a significant effect of the centre covariate (pseudo-F = 2.51; p = 0.001) on the weighted 243 UniFrac 32 distances, while the diagnosis covariate was not significant (pseudo-F = 1.66; p = 0.1). 244
We also performed Principal Coordinates Analysis (PCoA) on the Weighted-UniFrac distance matrix. 245
This did not show clustering by disease state ( Figure 2C and 2D ), although the plot may suggest a 246 distribution amenable to unsupervised clustering. Patients tended to cluster into three groups on a 247 continuum on the PCoA. These individual clusters could represent specific microbial community types, 248 similar to what has been previously reported by Cope et al. 23 Investigation into the constitution of these 249 groupings, and their association with underlying clinical or pathological factors in a large multi-250 institutional cohort remains a topic of future investigation. 251
The core sinonasal microbiome is composed of five genera 252
We defined a core sinonasal microbiome by analysing the most abundant organisms along with their 253 cumulative prevalence. This was performed across all samples and also across the three different disease 254 groups. The results of this investigation confirmed a high prevalence of the top five abundant genera 255 (Corynebacterium, Staphylococcus, Streptococcus, Haemophilus, and Moraxella), which together reached 256 a cumulative prevalence in 98-100% of samples in all patient groups. Presence of at least one of these 257 taxa in nearly all patients suggests that they make up the core sinonasal microbiome, regardless of disease 258 status ( Figure 3 ). Amongst control patients, Corynebacterium and Staphylococcus were present in 98.6% 259 of patients, again suggesting a likely key commensal function of these two genera in the healthy state. 260 To determine whether any host factors may contribute to the stability of the sinonasal microbiome, 268 patients were separated by known clinical variables that contribute to CRS (Figure 4 ). There were no 269 significant differential abundances (of the 10 topmost abundant genera) for all six clinical covariates 270 examined (asthma, aspirin sensitivity, diabetes, gastro-oesophageal reflux disease, smoking status and 271 primary-versus-revision surgery). These tests were also repeated for CRS only subgroup and showed no 272 significantly differentially abundant genera across the different covariate levels. 273 The present study characterises the sinonasal microbiome in a large cohort of subjects from centres 281 around the world using 16S rRNA surveillance. By adopting a unified, consistent methodology from 282 sample acquisition to analysis we have been able to address many of the current existing limitations of 283 currently available data. 284
We have identified Corynebacterium, Staphylococcus, Moraxella, Streptococcus and Haemophilus as the 285 most abundant genera within the middle meatus of patients with or without CRS. This consistent finding 286 across disease state and geography suggests that these organisms may form the core microbiome within 287 the sinonasal tract. Interestingly, Streptococcus, Moraxella and Haemophilus species are traditionally 288 respiratory tract organisms and constitute the most commonly cultured pathogens in patients with acute 289 bacterial tonsillitis, otitis media and acute sinusitis. 13,33-35 Anatomically, the sinonasal tract connects these 290 three distinct anatomical regions and while these organisms appear to be commensals, so it is possible 291 that the sinuses act as a reservoir for these organisms to subsequently initiate acute infection. While 292 relatively low bacterial burden is present within the sinonasal mucosa, a dysbiosis within the diseased 293 state may lead to over-representation of these organisms that subsequently lead to acute infectious or 294 inflammatory processes. 295
While variations across geography have been demonstrated in the gut microbiome 1 and have been 296 suspected within the sinuses, 36 this is the first study to examine this using standardized methodology. Our 297 results suggest that although the bacterial composition of the core microbiome was preserved across the 298 different sites, significant differences in both alpha and beta diversity occurred according to geography. 299 Furthermore, microbiome composition also varied between centres. Most centres demonstrated a similar 300 consistency in relative abundances of Corynebacterium and Staphylococcal species. Some centres, 301 however, appeared to exhibit a varying microbial ecology of the less abundant organisms, which were 302 either over-or under-represented. The most distinct microbial distribution was observed in samples 303 collected from the Amsterdam centre, which appeared to be the most distinct centre with depletion in 304
Corynebacterium and over-representation in Staphylococcus. Interestingly, antibiotic use in The 305
Netherlands is amongst the lowest in the developed world. 37 Such practices may influence the microbiota 306 through selective microbial suppression and could partially account for the unique microbiome observed 307 in Amsterdam. Overall, these findings suggest that there are differences in the sinonasal microbiome 308 composition across geographical regions, but these differences would not alter the general pattern of core 309 Cyanobacterium, for example is an environmental organism and Bacteroidetes is typically associated 317 with the colon. [39] [40] [41] In light of the limitations of current methodologies, reports of airway organisms that 318 are novel, rare, and that do not form a part of the core microbiome, should therefore be interpreted 319 cautiously. It is expected that the resolution of identification and functional characterization of bacterial 320 species and strains in the sinuses can only improve, with advancement in sequencing technologies. 321
The organisms Corynebacterium and Staphylococcus are of particular interest. It was interesting to note 322 that these organisms remained the two most abundant genera across geographical divides. Furthermore, 323 amongst our control cohort, they were present in almost all individuals, again suggesting a key 324 commensal function in the healthy state. Our findings of great abundance in both healthy patients and 325 CRS patients mirrors previous studies. 22 While Corynebacterium has traditionally been thought of as a 326 nasal commensal, 42 some studies suggest that certain species such as C. tuberculostearicum may be 327 involved in CRS pathogenesis. 43 We could not resolve the Corynebacterium genus in our current analysis to the species level, given the limitations of short-read 16S rRNA gene sequencing, but it is likely that a 329 number of different corynebacterial species reside within the nose -the majority as commensals. Recent 330 evidence shows that certain species of Corynebacterium are beneficial in the nasal airways. 331 Corynebacterium accolens, for example, is a common nasal colonizer, and can inhibit streptococcal 332 growth by releasing oleaic acids through hydrolysis of host triacylglycerols. 44 CRS. This study is the largest yet to describe the sinus microbiome and the first to examine geographical 360 variation. We demonstrate that the core microbiome is composed of Corynebacterium, Staphylococcus, 361
Streptococcus, Moraxella and Haemophilus. These organisms are present across disease phenotypes and 362 countries. Utilising a large cohort and standardised methodology has allowed us to better characterise the 363 sinonasal microbiome. By doing so, we have presented a foundation for future prospective studies into 364 pathological states as well as functional analysis. 365 366
Participating centres 368
A total of fourteen centres participated in the completion of this investigation. Thirteen centres provided 369 patient samples for utilisation within the study. One centre (Northern Arizona University) provided 370 bioinformatics expertise and consultation. The project was approved by the respective institutional human 371 research ethics boards of all sample-collection centres (Table S1 ). Participating centres are listed below: 372 
Study design 387
This study was a multi-centre, international collaborative investigation with a prospective, cross-sectional 388 design. In total, thirteen centres across 9 countries provided samples for analysis. Written consent to 389 tissue and clinical data collection was procured from all participants prior to surgery. Tris-Cl, pH8; 2mM sodium EDTA; 1.2% Triton X-100, filter sterilised; Sigma, St Louis, USA) was 428 added to each sample and left overnight at room temperature. Samples were then homogenised using 429 5mm steel beads and a Tissue Lyser II (Qiagen, Hilden, Germany) at 15Hz for 20 seconds. Steel beads 430 were then removed prior to further homogenisation with 50mg glass beads, again using the Tissue Lyser 431 II at 30Hz for 5 minutes. Proteinase K and Buffer AL (Qiagen, Hilden, Germany) were added to each 432 sample and left to incubate for 30 minutes at 56°C. Tubes were then centrifuged briefly to collect beads 433 and supernatant transferred to a fresh microcentrifuge tube. After addition of 100% ethanol to 434 supernatant, the new mixture was pipetted into DNeasy Mini Spin columns (Qiagen, Hilden, Germany). 435 Subsequent extraction of DNA from supernatant mixture was as per manufacturer instructions, with a 436 total of 100ul of DNA extracted per sample. Concentration was determined using a NanoDrop 1000 437 Spectrophotometer (Thermo Scientific, Massachusetts, USA). Extracted DNA was stored at -80°C until 438 sequencing. Any samples that were suspected to be improperly handled, contaminated or did not pass 439 quality control during processing were excluded. A total of 532 samples (126 CRSsNP; 212 CRSwNP; 440
194 Controls) passed all stages of transport and processing to be sent to the sequencing facility 441 (Australian Genome Research Facility; AGRF, Melbourne, Vic, Australia). 
